138 - Visualizing Infections Using Molecular Imaging

Saturday, October 2, 2021

1:15 PM - 3:00 PM EDT

Moderator(s)

Michael Glickman, MD, FIDSA, FAAM

Member, Attending Physician
Memorial Sloan Kettering
New York, NY, United States

Fimbrion Therapeutics (Individual(s) Involved: Self): Consultant; Pathogen Response Lab (Individual(s) Involved: Self): Board Member; Vedanta Biosciences (Individual(s) Involved: Self): Board Member, Shareholder
Anne-Catrin Uhlemann, MD, PhD

Associate Professor
Medicine/Infectious Diseases
Columbia University Irving Medical Center
New York, NY, United States

Merck (Individual(s) Involved: Self): Grant/Research Support

Speaker(s)

Sanjay Jain, MD

Professor
Johns Hopkins, United States

Fujirebio Diagnostics, Inc., USA (Individual(s) Involved: Self): Research Grant or Support; Novobiotic LLC, USA (Individual(s) Involved: Self): Research Grant or Support; T3 Pharma, Switzerland (Individual(s) Involved: Self): Research Grant or Support
Dima Hammoud, MD

Senior Investigator
NIH Clinical Center
Bethesda, MD, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Veronique Dartois, PhD

Professor
Hackensack Meridian School of Medicine, and Center for Dsicovery and Innovation
Nutley, NJ, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:

Michael S. Glickman, MD, FIDSA, FAAM: Fimbrion Therapeutics (Individual(s) Involved: Self): Consultant; Pathogen Response Lab (Individual(s) Involved: Self): Board Member; Vedanta Biosciences (Individual(s) Involved: Self): Board Member, Shareholder

Anne-Catrin Uhlemann, MD, PhD: Merck (Individual(s) Involved: Self): Grant/Research Support

Sanjay K. Jain, MD: Fujirebio Diagnostics, Inc., USA (Individual(s) Involved: Self): Research Grant or Support; Novobiotic LLC, USA (Individual(s) Involved: Self): Research Grant or Support; T3 Pharma, Switzerland (Individual(s) Involved: Self): Research Grant or Support

Dima A. Hammoud, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Veronique Dartois, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.75 hours of MOC Credit
ACPE Credits: ACPE 1.75 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

list potential future uses of imaging for specific diagnosis of infectious diseases
explain the role of drug distribution within tissues in treatment response
distinguish imaging markers of infection and inflammation

Presentations:

Bugs, Drugs and Star Trek! New Imaging Tools for Precision Medicine Approaches for Infections
Speaker: Sanjay K. Jain, MD – Johns Hopkins
Molecular Imaging of CNS Infection and Inflammation
Speaker: Dima A. Hammoud, MD – NIH Clinical Center
Molecular Imaging of Drug Distribution in Tuberculosis Lesions
Speaker: Veronique Dartois, PhD – Hackensack Meridian School of Medicine, and Center for Dsicovery and Innovation